Advertisement
Product › Details
pharmaceutical
Record changed: 2024-09-24 |
Advertisement
More documents for pharmaceutical
- [1] Biotest AG. (10/29/24). "Press Release: Biotest and SteinCares Partner to Improve Access to Plasma-derived Products in Latin America". Dreieich....
- [2] Kynos Therapeutics Ltd.. (10/29/24). "Press Release: Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio". Freiburg....
- [3] Valanx Biotech GmbH. (10/29/24). "Press Release: Valanx Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development". Klosterneuburg & Rockville, MD....
- [4] Ottimo Pharma Ltd.. (10/28/24). "Press Release: Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 20...
- [5] Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA....
- [6] |transkript [Kääb, Georg]. (10/21/24). "Miltenyi Biotec: An Exclusive, Rare Interview with Founder Stefan Miltenyi. Interview by |transkript.de/Georg Kääb"....
- [7] Cosmo Pharmaceuticals N.V.. (10/11/24). "Press Release: Cosmo Pharmaceuticals Appoints New Chief Financial Officer". Dublin....
- [8] Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Proposed $150 Million Public Offering". Houston, TX & Tübingen....
- [9] Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Updated Phase 1b Clinical Data on ACTengine IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial". Houston, TX & Tübingen....
- [10] Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top